![](https://endpts.com/wp-content/uploads/2023/10/Tom-Miller-Iambic-Therapeutics-CEO.jpg)
Tom Miller, Iambic Therapeutics CEO
Correction: Iambic says new AI model bests AlphaFold as protein models rocket ahead
The second-generation of Iambic Therapeutics’ AI model that predicts the combined shape of proteins and small molecules outperforms Google DeepMind’s AlphaFold, the San Diego biotech’ …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.